Genetic basis for glaucoma uncovered

January 30, 2018 by Will Doss, Northwestern University
Acute angle closure glaucoma of the right eye (intraocular pressure was 42 in the right eye). Credit: James Heilman, MD/Wikipedia

In two recent publications, Northwestern Medicine scientists and international collaborators discovered mutations that cause improper drainage and a buildup of ocular pressure leading to one form of congenital glaucoma, and identified a path towards future treatments for the disease.

Susan Quaggin, MD, chief of Nephrology and Hypertension in the Department of Medicine and director of the Feinberg Cardiovascular Research Institute, was senior author on the studies, the first published in the Journal of Clinical Investigation (JCI) and the second published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Glaucoma is a leading cause of blindness around the globe, and elevated intraocular pressure (IOP) is an important risk factor for the disease. Developmental defects in the anterior chamber of the eye, including a drainage vessel called Schlemm's canal, can lead to a particularly severe form of glaucoma in children known as primary (PCG).

"This special vessel acts like the drainpipes in a bathtub—to prevent the eye from 'overfilling,' " said Quaggin, also the Charles H. Mayo, MD, Professor and a professor of Medicine in the Division of Nephrology and Hypertension.

Previous studies from Quaggin and her collaborators have shown loss-of-function mutations in the angiopoietin (ANGPT) receptor TIE2/TEK in families with PCG, and that ANGPT/TIE2 pathway activity is critical for Schlemm's canal development.

Uncovering the genetic roots of congenital glaucoma

In the JCI study, Quaggin and her colleagues used mice models to explore the importance of individual components of the ANGPT/TEK pathway, finding mice without the growth factor ANGPT1 had severely deformed and small Schelmm's canals. In addition, loss of TIE2/TEK, the angiopoietin receptor, had a similar effect.

"Both ANGPT1 and TIE2/TEK are essential to form the drainage system of the eye to regulate and prevent Glaucoma," Quaggin said. "We believe it's highly likely that this pathway is also important in common forms of elevated IOP glaucoma, with over 60 million individuals affected by this disease worldwide."

Investigators found two human subjects with loss-of-function mutations in ANGPT1 within an international group of PCG patients, further supporting a causative role for ANGPT1 in the disease, according to Quaggin.

"These discoveries highlight the central role of this molecular pathway in glaucoma and provide sign posts guiding us to a new therapy," Quaggin said.

Flipping the Switch

In the PNAS study, Quaggin and her colleagues searched for ways to influence the molecular pathway they'd identified. In particular, inhibition of TIE2/TEK has been linked to vessel leakage and inflammation, so finding a way to activate TIE2/TEK was a priority.

"To develop a new and much needed therapy to 'fix' these vessels and lower the pressure inside the eye to prevent or treat , we need to understand how to turn the molecules 'on' and 'off,' " Quaggin said.

Again using mouse models, investigators found inhibition of a protein called VEPTP allowed ANGPT2 to be used as a TIE2/TEK activator, providing a blueprint for a pharmacological solution, according to Quaggin.

"We are currently well underway to developing new small molecule drugs to improve drainage through the Schlemm's canal and associated outflow vessels," Quaggin said. "We are also screening other patients and looking for other mutations in the pathway."

Explore further: Disease that causes blindness in children tied to new gene

More information: Benjamin R. Thomson et al. Angiopoietin-1 is required for Schlemm's canal development in mice and humans, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI95545

Tomokazu Souma et al. Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1714446115

Related Stories

Disease that causes blindness in children tied to new gene

June 10, 2016
Northwestern Medicine and University of Wisconsin-Madison (UW) scientists have identified a gene that causes severe glaucoma in children. The finding, published in The Journal of Clinical Investigation, validates a similar ...

New glaucoma cause discovered

September 9, 2014
Northwestern Medicine scientists have discovered a novel cause of glaucoma in an animal model, and related to their findings, are now developing an eye drop aimed at curing the disease. They believe their findings will be ...

Researchers report new paths to glaucoma treatment

September 19, 2017
Researchers at the Center for Vascular Research, within the Institute for Basic Science (IBS), have identified a new mechanism involved in the development and progression of glaucoma, and found a potential therapeutic option ...

Exploring the genetics of glaucoma and retinal development

November 10, 2017
Guillermo Oliver, PhD, the Thomas D. Spies Professor of Lymphatic Metabolism, recently published two studies related to the eye, one on retinal formation and the other on the genetics behind glaucoma.

Pilocarpine expands schlemm canal in healthy eyes, glaucoma

June 25, 2016
(HealthDay)—Pilocarpine expands the Schlemm canal in eyes with and without glaucoma, according to a study published online June 23 in JAMA Ophthalmology.

Study finds genetic link between thinner corneas and increased risk of glaucoma

January 25, 2018
Genetic studies in mice point to a protein called POU6F2, which can modulate corneal thickness, as a possible risk factor for glaucoma in humans, report Eldon Geisert of Emory University, and colleagues, January 25th in PLOS ...

Recommended for you

Injection improves vision in a form of childhood blindness

December 17, 2018
A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie Eye Institute in the ...

Researchers report vision-based neurotransmitter events for the first time

November 27, 2018
How does vision work, and what happens in the brain during the process? As simple as this question may sound, it has yet to be scientifically clarified. Dr. Valentin Riedl of the Technical University of Munich (TUM) and his ...

Minimally invasive retinal detachment has better outcomes, clinical trial findings

November 26, 2018
A minimally invasive treatment for retinal detachment gives patients sharper vision, less distortion and reduced side-effects, according to the findings of a randomized controlled trial performed at St. Michael's Hospital ...

Scientists combine technologies to view the retina in unprecedented detail

November 14, 2018
By combining two imaging modalities—adaptive optics and angiography—investigators at the National Eye Institute (NEI) can see live neurons, epithelial cells, and blood vessels deep in the eye's light-sensing retina. Resolving ...

Eyepatch with dissolvable needles used to treat eye disease

November 12, 2018
A team of researchers affiliated with several institutions in Singapore has developed an eyepatch with dissolvable needles for use in treating eye diseases. In their paper published in the journal Nature Communications, the ...

Calcifications in the eye increase risk for progression to advanced AMD by more than six times

November 8, 2018
Calcified nodules in the retina are associated with progression to late stages of age-related macular degeneration (AMD). Experts from Queen's University Belfast, working in partnership with the University of Alabama of Birmingham ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.